Quarterly Result6 Aug 2026, 08:10 pm
Jenburkt Pharmaceuticals Declares Q1 FY27 Unaudited Results
AI Summary
Jenburkt Pharmaceuticals Ltd announced its standalone unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results in a meeting held on August 6, 2026. The company operates exclusively in the Pharmaceuticals business segment, making segment-wise reporting not applicable. The financial results were reviewed by the Audit Committee and approved by the Board.
Key Highlights
- Standalone unaudited financial results for Q1 FY27 declared.
- Board of Directors approved the results on August 6, 2026.
- Company operates solely in the Pharmaceuticals segment.
- Audit Committee reviewed the financial results prior to Board approval.
Price Impact
More from JENBURPH